The important molecular pathways, such as the PI3K/PTEN/AKT/mTOR and RAS/RAF/MEK signaling pathways, have been examined for their participation in the development of endometrial cancer (Figure 10) (65, 66). This evidence concerns the gene AKT1 and endometrial cancer.